Last week, the EMA announced it has completed the reallocation of the medicines for which the UK's national regulator - the MHRA - is currently rapporteur or co-rapporteur appointed by the scientific committees to coordinate the evaluation of a medicine.
Earlier this week the British Medical Journal (BMJ) published and publicised a story which we believe inaccurately depicts the work of the pharmaceutical industry in the UK. Our chief executive Mike Thompson has written a letter to the BMJ in response.
The Association of the British Pharmaceutical Industry (ABPI) - representing leading global pharmaceutical businesses in the UK - have welcomed the EU Council's agreement to progress Brexit negotiations to the next phase and the EU Council's approval of a transition period.
This week the Health Research Authority and National Institute for Health Research jointly published a report of the general public's attitudes towards health research.
A new independent report from the Centre for Evaluation and Monitoring (CEM) at Durham University confirms that the Association of the British Pharmaceutical Industry (ABPI) is leading the way when it comes to the provision of high quality and robust professional development through the ABPI exam.
The ABPI are saddened to report the recent loss of Industry colleague Gary Noon.
The Association of the British Pharmaceutical Industry (ABPI) has responded to a provisional Competition & Markets Authority (CMA) ruling that a pharmaceutical company abused its dominant position to overcharge the NHS for liothyronine tablets.
The Association of the British Pharmaceutical Industry (ABPI) have issued a statement regarding its application for judicial review versus The National Institute for Health and Care Excellence (NICE).
Following a story published today in the Financial Times, the Association of the British Pharmaceutical Industry (ABPI) can confirm that it has applied for a Judicial Review.
Following today’s [26 July] announcement that Steve Oldfield will take up the role of Chief Commercial Officer at the Department of Health this October, the Association of the British Pharmaceutical Industry has issued the following statement.